Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Lung Cancer

  Free Subscription


Articles published in J Thorac Cardiovasc Surg

Retrieve available abstracts of 95 articles:
HTML format
Text format



Single Articles


    January 2019
  1. GUCKENBERGER M, Aerts JG, Van Schil P, Weder W, et al
    The American Society of Clinical Oncology-endorsed American Society for Radiation Oncology Evidence-Based Guideline of stereotactic body radiotherapy for early-stage non-small cell lung cancer: An expert opinion.
    J Thorac Cardiovasc Surg. 2019;157:358-361.
    PubMed     Text format    


    December 2018
  2. SAMSON P
    It's time to check our bias: Ensuring health equity for patients with lung cancer.
    J Thorac Cardiovasc Surg. 2018 Dec 27. pii: S0022-5223(18)33499.
    PubMed     Text format    


  3. HSIN MK, Ho JC
    It is not as bad as they say: The risks of surgery in screening-detected lung cancer are overstated.
    J Thorac Cardiovasc Surg. 2018 Dec 25. pii: S0022-5223(18)33482.
    PubMed     Text format    


  4. YANG CJ, Yendamuri S, Mayne NR, Battoo A, et al
    The role of thoracoscopic pneumonectomy in the management of non-small cell lung cancer: A multicenter study.
    J Thorac Cardiovasc Surg. 2018 Dec 18. pii: S0022-5223(18)33419.
    PubMed     Text format     Abstract available


  5. BOTT MJ, Yang SC, Park BJ, Adusumilli PS, et al
    Initial results of pulmonary resection after neoadjuvant nivolumab in patients with resectable non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018 Dec 13. pii: S0022-5223(18)33277.
    PubMed     Text format     Abstract available


  6. WOLF A, Alpert N, Tran BV, Liu B, et al
    Persistence of racial disparities in early-stage lung cancer treatment.
    J Thorac Cardiovasc Surg. 2018 Dec 11. pii: S0022-5223(18)33258.
    PubMed     Text format     Abstract available


  7. FERRARI-LIGHT D, Cerfolio RJ
    Are we really operating on advanced stage non-small cell lung cancer?
    J Thorac Cardiovasc Surg. 2018 Dec 4. pii: S0022-5223(18)33219.
    PubMed     Text format    


    November 2018
  8. FERNANDEZ FG, Kosinski AS, Tong BC, Furnary AP, et al
    Lack of correlation between short- and long-term performance after lung cancer surgery.
    J Thorac Cardiovasc Surg. 2018 Nov 27. pii: S0022-5223(18)33141.
    PubMed     Text format     Abstract available


  9. NELSON DB, Tayob N, Mitchell KG, Correa AM, et al
    Surgical margins and risk of local recurrence after wedge resection of colorectal pulmonary metastases.
    J Thorac Cardiovasc Surg. 2018 Nov 26. pii: S0022-5223(18)33149.
    PubMed     Text format     Abstract available


  10. DAVID EA, Andersen SW, Beckett LA, Melnikow J, et al
    Survival benefits associated with surgery for advanced non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018 Nov 14. pii: S0022-5223(18)32941.
    PubMed     Text format     Abstract available


  11. DONINGTON JS
    Keeping surgery relevant in oligometastatic non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018 Nov 8. pii: S0022-5223(18)32903.
    PubMed     Text format    


  12. HARRISON MS, Frye CC, Puri V
    Health metrics in lung cancer care: Measure, improve, repeat.
    J Thorac Cardiovasc Surg. 2018 Nov 2. pii: S0022-5223(18)32879.
    PubMed     Text format    


    October 2018
  13. KORST RJ, Santana-Joseph S
    Quality metrics for lung cancer care: Far from perfect, but close to reality.
    J Thorac Cardiovasc Surg. 2018 Oct 28. pii: S0022-5223(18)32858.
    PubMed     Text format    


  14. SUBRAMANIAN MP, Puri V
    Surveillance and the second primary lung cancer: Enhancing our understanding beyond Martini and Melamed.
    J Thorac Cardiovasc Surg. 2018 Oct 26. pii: S0022-5223(18)32833.
    PubMed     Text format    


  15. FARJAH F, Kessler L
    Rightsizing lung cancer surveillance.
    J Thorac Cardiovasc Surg. 2018 Oct 22. pii: S0022-5223(18)32803.
    PubMed     Text format    


  16. ZHANG Y, Chen H
    Neoadjuvant or adjuvant chemotherapy for non-small-cell lung cancer: Does the timing matter?
    J Thorac Cardiovasc Surg. 2018 Oct 12. pii: S0022-5223(18)32632.
    PubMed     Text format    


  17. BRUNELLI A
    The timing of chemotherapy in multimodality treatment of locally advanced lung cancer: One size does not fit all.
    J Thorac Cardiovasc Surg. 2018 Oct 10. pii: S0022-5223(18)32609.
    PubMed     Text format    


  18. BRANDT WS, Yan W, Zhou J, Tan KS, et al
    Outcomes after neoadjuvant or adjuvant chemotherapy for cT2-4N0-1 non-small cell lung cancer: A propensity-matched analysis.
    J Thorac Cardiovasc Surg. 2018 Oct 10. pii: S0022-5223(18)32606.
    PubMed     Text format     Abstract available


  19. WANG Y, Yeung JC, Hanna WC, Allison F, et al
    Metachronous or synchronous primary lung cancer in the era of computed tomography surveillance.
    J Thorac Cardiovasc Surg. 2018 Oct 6. pii: S0022-5223(18)32556.
    PubMed     Text format     Abstract available


    September 2018
  20. CAO C, Wang D, Chung C, Tian D, et al
    A systematic review and meta-analysis of stereotactic body radiation therapy versus surgery for patients with non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018 Sep 15. pii: S0022-5223(18)32347.
    PubMed     Text format     Abstract available


  21. ENGELHARDT KE, Feinglass JM, DeCamp MM, Bilimoria KY, et al
    Treatment trends in early-stage lung cancer in the United States, 2004 to 2013: A time-trend analysis of the National Cancer Data Base.
    J Thorac Cardiovasc Surg. 2018;156:1233-1246.
    PubMed     Text format     Abstract available


    August 2018
  22. FERNANDEZ-RODRIGUEZ L, Torres I, Romera D, Galera R, et al
    Prediction of postoperative lung function after major lung resection for lung cancer using volumetric computed tomography.
    J Thorac Cardiovasc Surg. 2018 Aug 2. pii: S0022-5223(18)32018.
    PubMed     Text format     Abstract available


    July 2018
  23. LIN J, Fernandez F
    Indications for invasive mediastinal staging for non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018 Jul 21. pii: S0022-5223(18)31872.
    PubMed     Text format    


  24. HOANG CD
    Adjuvant chemotherapy in stage I lung cancer: Is more better?
    J Thorac Cardiovasc Surg. 2018 Jul 19. pii: S0022-5223(18)31821.
    PubMed     Text format    


  25. WANG S, Xu J, Wang R, Qian F, et al
    Adjuvant chemotherapy may improve prognosis after resection of stage I lung cancer with lymphovascular invasion.
    J Thorac Cardiovasc Surg. 2018 Jul 18. pii: S0022-5223(18)31779.
    PubMed     Text format     Abstract available


  26. UPHAM TC, Onaitis MW
    Video-assisted thoracoscopic surgery versus robot-assisted thoracoscopic surgery versus thoracotomy for early-stage lung cancer.
    J Thorac Cardiovasc Surg. 2018;156:365-368.
    PubMed     Text format    


    June 2018
  27. SCHRUMP DS, Hong JA
    Analysis of circulating tumor DNA: The next paradigm shift in detection and treatment of lung cancer.
    J Thorac Cardiovasc Surg. 2018;155:2632-2633.
    PubMed     Text format    


    May 2018
  28. HATTORI A, Suzuki K
    New era defining a novel clinical T staging in non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018;155:2179-2180.
    PubMed     Text format    


    April 2018
  29. SWANSON SJ
    Good vibrations-better care for lung cancer patients.
    J Thorac Cardiovasc Surg. 2018 Apr 13. pii: S0022-5223(18)30994.
    PubMed     Text format    


  30. BRUNELLI A
    It is not just about surgery versus stereotactic ablative radiotherapy, it is about curing as many patients with lung cancer as possible.
    J Thorac Cardiovasc Surg. 2018 Apr 12. pii: S0022-5223(18)30962.
    PubMed     Text format    


  31. OKIROR L, Harling L, Toufektzian L, King J, et al
    Prognostic factors including lymphovascular invasion on survival for resected non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018 Apr 12. pii: S0022-5223(18)30935.
    PubMed     Text format     Abstract available


  32. CAO J, Xu J, He Z, Yuan P, et al
    Prognostic impact of lymphadenectomy on outcomes of sublobar resection for stage IA non-small cell lung cancer </=2 cm.
    J Thorac Cardiovasc Surg. 2018 Apr 6. pii: S0022-5223(18)30905.
    PubMed     Text format     Abstract available


  33. YENDAMURI S, Dhillon SS, Groman A, Dy G, et al
    Effect of the number of lymph nodes examined on the survival of patients with stage I non-small cell lung cancer who undergo sublobar resection.
    J Thorac Cardiovasc Surg. 2018 Apr 4. pii: S0022-5223(18)30895.
    PubMed     Text format     Abstract available


  34. MAO Q, Xia W, Dong G, Chen S, et al
    A nomogram to predict the survival of stage IIIA-N2 non-small cell lung cancer after surgery.
    J Thorac Cardiovasc Surg. 2018;155:1784-1792.
    PubMed     Text format     Abstract available


    March 2018
  35. KRUSER TJ, Mohindra N, DeCamp MM
    One size does not fit all: Nuances in postoperative N2 non-small cell lung cancer management.
    J Thorac Cardiovasc Surg. 2018 Mar 29. pii: S0022-5223(18)30865.
    PubMed     Text format    


  36. ISBELL JM, Jones DR, Li BT
    Circulating tumor DNA: A promising biomarker to guide postoperative treatment and surveillance of non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018 Mar 13. pii: S0022-5223(18)30707.
    PubMed     Text format    


  37. AJMANI GS, Wang CH, Kim KW, Howington JA, et al
    Surgical quality of wedge resection affects overall survival in patients with early stage non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018 Mar 13. pii: S0022-5223(18)30776.
    PubMed     Text format     Abstract available


  38. CAMERON RB
    Adherence to lung cancer surgical quality standards is critical for the survival of both our patients and our specialty.
    J Thorac Cardiovasc Surg. 2018 Mar 7. pii: S0022-5223(18)30612.
    PubMed     Text format    


  39. SU K, Gao S, Ying J, Zou S, et al
    Sequencing a super multiple synchronous lung cancer reveals a novel variant in driver gene ARID1B.
    J Thorac Cardiovasc Surg. 2018 Mar 6. pii: S0022-5223(18)30059.
    PubMed     Text format    


  40. ROCCO G
    Every breath you take: The value of the electronic nose (e-nose) technology in the early detection of lung cancer.
    J Thorac Cardiovasc Surg. 2018 Mar 2. pii: S0022-5223(18)30604.
    PubMed     Text format    


  41. BRUNELLI A
    Short-term outcomes do not capture the real value of lung cancer surgery.
    J Thorac Cardiovasc Surg. 2018;155:1311-1312.
    PubMed     Text format    


  42. MEHRAN RJ, Martin LW, Roth JA
    Comparison of outcomes between muscle-sparing thoracotomy and video-assisted thoracic surgery in patients with cT1 N0 M0 lung cancer.
    J Thorac Cardiovasc Surg. 2018;155:1307.
    PubMed     Text format    


    February 2018
  43. SEPESI B, Ye Y, Mitchell KG, Zhang L, et al
    Genetic variants in cytokine signaling pathways and clinical outcomes in early-stage lung cancer patients.
    J Thorac Cardiovasc Surg. 2018 Feb 15. pii: S0022-5223(18)30372.
    PubMed     Text format     Abstract available


  44. CHENG X, Zheng D, Li Y, Li H, et al
    Tumor histology predicts mediastinal nodal status and may be used to guide limited lymphadenectomy in patients with clinical stage I non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018 Feb 13. pii: S0022-5223(18)30362.
    PubMed     Text format     Abstract available


  45. MUNOZ-LARGACHA JA, Steiling KA, Kathuria H, Charlot M, et al
    Initial surgical experience following implementation of lung cancer screening at an urban safety net hospital.
    J Thorac Cardiovasc Surg. 2018 Feb 9. pii: S0022-5223(18)30308.
    PubMed     Text format     Abstract available


  46. THORNBLADE LW, Wood DE, Mulligan MS, Farivar AS, et al
    Variability in invasive mediastinal staging for lung cancer: A multicenter regional study.
    J Thorac Cardiovasc Surg. 2018 Feb 9. pii: S0022-5223(18)30311.
    PubMed     Text format     Abstract available


  47. RUSTHOVEN CG, Jones BL, Kavanagh BD
    Medical operability and inoperability drive survival in retrospective analyses comparing surgery and SBRT for early-stage lung cancer.
    J Thorac Cardiovasc Surg. 2018;155:810-811.
    PubMed     Text format    


    January 2018
  48. AHMAD U, Machuzak M
    Electric shock therapy for lung cancer: Taking palliation to the next level.
    J Thorac Cardiovasc Surg. 2018 Jan 31. pii: S0022-5223(18)30245.
    PubMed     Text format    


  49. MOGHANAKI D, Simone CB 2nd, Rimner A, Karas TZ, et al
    The value of collaboration between thoracic surgeons and radiation oncologists while awaiting evidence in operable stage i non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018;155:429-431.
    PubMed     Text format    


    December 2017
  50. NOMORI H, Shiraishi A, Cong Y, Shoji K, et al
    Impact of induction chemoradiotherapy on pulmonary function after lobectomy for lung cancer.
    J Thorac Cardiovasc Surg. 2017 Dec 26. pii: S0022-5223(17)33059.
    PubMed     Text format     Abstract available


  51. RUSCH VW, Chaft J, Hellmann M
    KEYNOTE-024: Unlocking a pathway to lung cancer cure?
    J Thorac Cardiovasc Surg. 2017 Dec 23. pii: S0022-5223(17)33029.
    PubMed     Text format    


  52. ROGERS LJ, Bleetman D, Messenger DE, Joshi NA, et al
    The impact of enhanced recovery after surgery (ERAS) protocol compliance on morbidity from resection for primary lung cancer.
    J Thorac Cardiovasc Surg. 2017 Dec 19. pii: S0022-5223(17)32855.
    PubMed     Text format     Abstract available


  53. DRAKE JA, Sullivan JL, Weksler B
    Adjuvant chemotherapy improves survival in patients with completely resected T3N0 non-small cell lung cancer invading the chest wall.
    J Thorac Cardiovasc Surg. 2017 Dec 19. pii: S0022-5223(17)32857.
    PubMed     Text format     Abstract available


  54. DIGESU CS, Hachey KJ, Gilmore DM, Khullar OV, et al
    Long-term outcomes after near-infrared sentinel lymph node mapping in non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2017 Dec 13. pii: S0022-5223(17)32505.
    PubMed     Text format     Abstract available


  55. BRUNELLI A
    Time of modeling survival of patients with stage III-N2 non-small cell lung cancer: Before or after surgery makes a difference.
    J Thorac Cardiovasc Surg. 2017 Dec 12. pii: S0022-5223(17)32837.
    PubMed     Text format    


    November 2017
  56. GELLER AD, Zheng H, Mathisen DJ, Wright CD, et al
    Relative incremental costs of complications of lobectomy for stage I non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2017 Nov 20. pii: S0022-5223(17)32702.
    PubMed     Text format     Abstract available


  57. NEGRAO MV, Quek K, Zhang J, Sepesi B, et al
    TRACERx: Tracking tumor evolution to impact the course of lung cancer.
    J Thorac Cardiovasc Surg. 2017 Nov 16. pii: S0022-5223(17)32689.
    PubMed     Text format    


  58. FERNANDEZ FG, Kosinski AS, Furnary AP, Onaitis M, et al
    Differential effects of operative complications on survival after surgery for primary lung cancer.
    J Thorac Cardiovasc Surg. 2017 Nov 13. pii: S0022-5223(17)32503.
    PubMed     Text format     Abstract available


  59. WEKSLER B
    Resection of pleural implants in patients with lung cancer should remain the exception rather than the rule.
    J Thorac Cardiovasc Surg. 2017 Nov 8. pii: S0022-5223(17)32459.
    PubMed     Text format    


  60. LIN J
    Resection of primary lung cancer with incidental pleural seeding: Seeds of change or reap what you sow?
    J Thorac Cardiovasc Surg. 2017 Nov 6. pii: S0022-5223(17)32471.
    PubMed     Text format    


  61. CHENG X, Chen H
    Commentary on the impacts of postoperative complications on survival after lung cancer surgery.
    J Thorac Cardiovasc Surg. 2017 Nov 6. pii: S0022-5223(17)32470.
    PubMed     Text format    


  62. ZHENG D, Ye T, Hu H, Zhang Y, et al
    Upfront surgery as first-line therapy in selected patients with stage IIIA non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2017 Nov 3. pii: S0022-5223(17)32409.
    PubMed     Text format     Abstract available


  63. LIU M, Wigle D, Wampfler JA, Dai J, et al
    T category of non-small cell lung cancer invading the fissure to the adjacent lobe.
    J Thorac Cardiovasc Surg. 2017;154:1777-1783.
    PubMed     Text format     Abstract available


  64. LANUTI M
    Risk stratification for distant recurrence of resected early stage non-small cell lung cancer is under construction.
    J Thorac Cardiovasc Surg. 2017 Nov 1. pii: S0022-5223(17)32392.
    PubMed     Text format    


    October 2017
  65. MOLENA D
    Shining light on sentinel node assessment for lung cancer: Quality is superior to quantity.
    J Thorac Cardiovasc Surg. 2017 Oct 20. pii: S0022-5223(17)32331.
    PubMed     Text format    


    September 2017
  66. DETTERBECK FC
    The eighth edition TNM stage classification for lung cancer: What does it mean on main street?
    J Thorac Cardiovasc Surg. 2017 Sep 28. pii: S0022-5223(17)32136.
    PubMed     Text format    


  67. ZHANG Z, Mostofian F, Ivanovic J, Gilbert S, et al
    All grades of severity of postoperative adverse events are associated with prolonged length of stay after lung cancer resection.
    J Thorac Cardiovasc Surg. 2017 Sep 28. pii: S0022-5223(17)32135.
    PubMed     Text format     Abstract available


  68. TURNA A, Melek H, Kara HV, Kilic B, et al
    Validity of the updated European Society of Thoracic Surgeons staging guideline in lung cancer patients.
    J Thorac Cardiovasc Surg. 2017 Sep 27. pii: S0022-5223(17)32131.
    PubMed     Text format     Abstract available


  69. CERFOLIO RJ, Ghanim AF, Dylewski M, Veronesi G, et al
    The long-term survival of robotic lobectomy for non-small cell lung cancer: A multi-institutional study.
    J Thorac Cardiovasc Surg. 2017 Sep 18. pii: S0022-5223(17)31919.
    PubMed     Text format     Abstract available


  70. GILBERT CR, Ely R, Fathi JT, Louie BE, et al
    The economic impact of a nurse practitioner-directed lung cancer screening, incidental pulmonary nodule, and tobacco-cessation clinic.
    J Thorac Cardiovasc Surg. 2017 Sep 13. pii: S0022-5223(17)31890.
    PubMed     Text format     Abstract available


  71. SEDER CW
    Lung cancer screening is here to stay, but does it pay?
    J Thorac Cardiovasc Surg. 2017 Sep 12. pii: S0022-5223(17)31887.
    PubMed     Text format    


  72. ANTONOFF MB
    Multifocal lung cancer within ground glass lesions: Are favorable outcomes consequent to surgical resection or inherent to the disease?
    J Thorac Cardiovasc Surg. 2017 Sep 8. pii: S0022-5223(17)31866.
    PubMed     Text format    


  73. TONG BC
    Lung cancer screening: No more excuses.
    J Thorac Cardiovasc Surg. 2017 Sep 5. pii: S0022-5223(17)31853.
    PubMed     Text format    


  74. LIU C, Liu L
    Reappraise the advanced technique for tumor localization and sentinel lymph node assessment in clinical early-stage non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2017;154:1134.
    PubMed     Text format    


  75. DIGESU CS, Colson YL
    A "green" light for staging in early lung cancer.
    J Thorac Cardiovasc Surg. 2017;154:1134-1136.
    PubMed     Text format    


  76. FLORES RM
    Lung cancer randomized controlled trials should compare stereotactic body radiation therapy with observation, NOT surgery.
    J Thorac Cardiovasc Surg. 2017 Sep 1. pii: S0022-5223(17)31820.
    PubMed     Text format    


  77. KIDANE B
    Stereotactic body radiation therapy versus video-assisted thoracoscopic surgery in stage I lung cancer: Honesty in the face of uncertainty.
    J Thorac Cardiovasc Surg. 2017 Sep 1. pii: S0022-5223(17)31821.
    PubMed     Text format    


  78. HATTORI A, Matsunaga T, Takamochi K, Oh S, et al
    Prognostic impact of a ground glass opacity component in the clinical T classification of non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2017 Sep 1. pii: S0022-5223(17)31798.
    PubMed     Text format     Abstract available


  79. BURT BM
    Programmed death ligand 1-associated antitumor immunity in early-stage non-small cell lung cancer: Expression of major histocompatibility complex I as a prerequisite.
    J Thorac Cardiovasc Surg. 2017 Sep 1. pii: S0022-5223(17)31823.
    PubMed     Text format    


    August 2017
  80. CORNWELL LD, Echeverria AE, Samuelian J, Mayor J, et al
    Video-assisted thoracoscopic lobectomy is associated with greater recurrence-free survival than stereotactic body radiotherapy for clinical stage I lung cancer.
    J Thorac Cardiovasc Surg. 2017 Aug 16. pii: S0022-5223(17)31718.
    PubMed     Text format     Abstract available


    July 2017
  81. FERNANDEZ FG
    What are the gaps in quality measurement for lung cancer surgery?
    J Thorac Cardiovasc Surg. 2017 Jul 1. pii: S0022-5223(17)31367.
    PubMed     Text format    


    June 2017
  82. SCHAHEEN LW, D'Cunha J
    The slippery slope of nonoperative therapy in early-stage lung cancer.
    J Thorac Cardiovasc Surg. 2017 Jun 10. pii: S0022-5223(17)31178.
    PubMed     Text format    


  83. BRANDT WS, Isbell JM, Jones DR
    Defining quality in the surgical care of lung cancer patients.
    J Thorac Cardiovasc Surg. 2017 Jun 9. pii: S0022-5223(17)31171.
    PubMed     Text format    


    May 2017
  84. CHEN K, Zhang J, Guan T, Yang F, et al
    Comparison of plasma to tissue DNA mutations in surgical patients with non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2017 May 24. pii: S0022-5223(17)31084.
    PubMed     Text format     Abstract available


  85. ZHAO Y, Li G, Zhang Y, Hu H, et al
    Comparison of outcomes between muscle-sparing thoracotomy and video-assisted thoracic surgery in patients with cT1 N0 M0 lung cancer.
    J Thorac Cardiovasc Surg. 2017 May 20. pii: S0022-5223(17)31049.
    PubMed     Text format     Abstract available


  86. NGUYEN DM, Villamizar N
    "One-stop shop" tumor tattooing and sentinel lymph node mapping: A new paradigm for lung cancer therapy.
    J Thorac Cardiovasc Surg. 2017 May 17. pii: S0022-5223(17)30908.
    PubMed     Text format    


    April 2017
  87. WEKSLER B
    One in every 14 patients with early-stage lung cancer is not being treated!
    J Thorac Cardiovasc Surg. 2017 Apr 24. pii: S0022-5223(17)30850.
    PubMed     Text format    


  88. HOANG CD
    Protein-based prognostic biomarkers in lung cancer: Promise or pitfall?
    J Thorac Cardiovasc Surg. 2017 Apr 23. pii: S0022-5223(17)30851.
    PubMed     Text format    


  89. FERRARIS VA
    Interstitial lung disease and lung cancer: Decisions, precision, and tuna fish sandwiches.
    J Thorac Cardiovasc Surg. 2017 Apr 23. pii: S0022-5223(17)30848.
    PubMed     Text format    


  90. BURT BM
    Incompletely resected non-small cell lung cancer: Do we know how to handle a positive margin?
    J Thorac Cardiovasc Surg. 2017 Apr 12. pii: S0022-5223(17)30689.
    PubMed     Text format    


  91. BERRY MF
    Evidence for resection of sarcoma pulmonary metastases: More, but better?
    J Thorac Cardiovasc Surg. 2017 Apr 7. pii: S0022-5223(17)30658.
    PubMed     Text format    


  92. MCMURRY TL, Shah PM, Samson P, Robinson CG, et al
    Treatment of stage I non-small cell lung cancer: What's trending?
    J Thorac Cardiovasc Surg. 2017 Apr 5. pii: S0022-5223(17)30643.
    PubMed     Text format     Abstract available


  93. YEROKUN BA, Yang CJ, Gulack BC, Li X, et al
    A national analysis of wedge resection versus stereotactic body radiation therapy for stage IA non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2017 Apr 4. pii: S0022-5223(17)30639.
    PubMed     Text format     Abstract available


  94. TSUTANI Y, Mimura T, Kai Y, Ito M, et al
    Outcomes after lobar versus sublobar resection for clinical stage I non-small cell lung cancer in patients with interstitial lung disease.
    J Thorac Cardiovasc Surg. 2017 Apr 4. pii: S0022-5223(17)30635.
    PubMed     Text format     Abstract available


  95. SMELTZER MP, Lin CC, Kong FS, Jemal A, et al
    Survival impact of postoperative therapy modalities according to margin status in non-small cell lung cancer patients in the United States.
    J Thorac Cardiovasc Surg. 2017 Apr 4. pii: S0022-5223(17)30604.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: